
PMC:7153689 / 3265-4011
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
59 | 660-668 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T26 | 660-668 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T17 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T18 | 111-116 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T19 | 302-307 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T20 | 388-393 | http://purl.obolibrary.org/obo/UBERON_0007688 | denotes | field |
T21 | 410-415 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T22 | 489-490 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T23 | 526-531 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T24 | 634-639 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 92-96 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T2 | 508-515 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 136-157 | http://purl.obolibrary.org/obo/GO_0001171 | denotes | reverse transcription |
T3 | 144-157 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T24 | 0-83 | Sentence | denotes | A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. |
T25 | 84-287 | Sentence | denotes | Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). |
T26 | 288-501 | Sentence | denotes | Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. |
T27 | 502-604 | Sentence | denotes | Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. |
T28 | 605-746 | Sentence | denotes | Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T35 | 84-91 | CHEBI:23447;GO:0005634;CHEBI:23447 | denotes | Nucleic |
T36 | 92-96 | CHEBI:37527;CHEBI:37527 | denotes | acid |
T37 | 136-157 | GO:0001171 | denotes | reverse transcription |
T38 | 355-365 | GO:0042571 | denotes | antibodies |
T39 | 508-515 | CHEBI:59132;CHEBI:59132 | denotes | antigen |
T40 | 660-668 | SP_7 | denotes | COVID-19 |
T41 | 708-719 | GO:0006953 | denotes | acute phase |
T3553 | 84-91 | CHEBI:23447;GO:0005634;CHEBI:23447 | denotes | Nucleic |
T57133 | 92-96 | CHEBI:37527;CHEBI:37527 | denotes | acid |
T47984 | 136-157 | GO:0001171 | denotes | reverse transcription |
T42493 | 355-365 | GO:0042571 | denotes | antibodies |
T14079 | 508-515 | CHEBI:59132;CHEBI:59132 | denotes | antigen |
T68472 | 660-668 | SP_7 | denotes | COVID-19 |
T3989 | 708-719 | GO:0006953 | denotes | acute phase |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32308536-32196430-66949961 | 284-285 | 32196430 | denotes | 7 |